| |
 |
Tamas Hamori Patents |
|
Inventor: Hamori; Tamas
Address: Budapest, HU
No. of patents: 23
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 6858605 |
Substituted 2,3-benzodiazepine derivatives |
February 22, 2005 |
| The invention relates to new 2,3-benzodiazepine derivatives of formula (I), isomers and acid addition salts thereof and to pharmaceutical compositions containing the same, as well as to pharmaceutical compositions and methods of using the same suitable for treating conditions associated |
| 6600036 |
Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors |
July 29, 2003 |
| Compounds of formula I are described, their production and use in pharmaceutical agents. ##STR1## |
| 6482819 |
2,3-benzodiazepine derivatives |
November 19, 2002 |
| 2,3-Benzodiazepines of formula (I), their stereoisomers and acid addition salts, ##STR1##wherein the variables have the meaning given in the specification, and pharmaceutical compositions containing them which are suitable for treating conditions associated with muscle spasms, epilep |
| 6323197 |
Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors |
November 27, 2001 |
| The invention concerns compounds of formula (I), in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 mean hydrogen or different substituents; X means hydrogen or halogen; Y means C.sub.1-6 alkoxy or X and Y together mean --O--(CH.sub.2).sub.n --O--; n means 1, 2 or 3; and A together with |
| 6200970 |
2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors |
March 13, 2001 |
| A compound of formula I ##STR1##in whichX means hydrogen or halogen,Y means --NR.sup.3 -- or --N.dbd.,R.sup.1 and R.sup.2 are the same or different and mean hydrogen, C.sub.1 -C.sub.6 alkyl, nitro, halogen, the group --NR.sup.8 R.sup.9, --O--C.sub.1-4 alkyl, --CF.sub.3, OH or C.sub.1-6 a |
| 6075018 |
1-[2-(substituted vinyl)]-3,4-dihydro-4-dihydro-5H-2,3-benzodiazepine derivatives |
June 13, 2000 |
| The invention relates to new 1-[2-(substituted vinyl)]-3,4-dihydro-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof and pharmaceutical compositions comprising them. The new 1-[2-(substituted vinyl)]-3,4-dihidro-5H-2,3-benzodiazepine derivatives according to th |
| 5942506 |
1-[2-(substituted vinyl)]-5H-2,3-benzodiazepine derivatives |
August 24, 1999 |
| This invention relates to new 1-[2-(substituted vinyl)]-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said benzodiazepine derivatives for the treatment of diseases and for the preparation o |
| 5807851 |
2,3-Benzodiazepine Derivatives as non-competitive AMPA |
September 15, 1998 |
| Derivatives of 2,3-benzodiazepine are substituted by one or two halogen atom(s) and have the general formula ##STR1## These derivatives are non-competitive AMPA antagonists and are used in pharmaceutical compositions. A process to make the 2,3-benzodiazepine derivatives includes |
| 5756495 |
3-substituted 3H-2, 3-benzodiazepine derivatives, the production and use as pharmaceutical agent |
May 26, 1998 |
| New 3-substituted 3H-2,3-benzodiazepine derivatives of general formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and n have the meanings indicated in the description, their production as well as their use as pharmaceutical agents are described. |
| 5639751 |
N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders |
June 17, 1997 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group |
| 5604223 |
N acyl 2 3 benzodiazepine derivatives pharmaceutical compositions containing them and process fo |
February 18, 1997 |
| The invention relates to novel N-acyl-2,3-benzodiazepine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in this specification, a |
| 5536832 |
N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions containing them and process fo |
July 16, 1996 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group |
| 5521174 |
N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of the skeletal musculatur |
May 28, 1996 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives and a method of treating spasms of the skeletal musculature therewith. |
| 5519019 |
N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process f |
May 21, 1996 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)R stands for a C.sub.1-6 alkanoyl group |
| 5459137 |
N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process f |
October 17, 1995 |
| The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I), defined in the specification, a m |
| 5288863 |
Process for the preparation of high-purity 1-(3-chloro-phenyl)-4-methyl-7,8-dimethoxy-5H-2,3-ben |
February 22, 1994 |
| The invention relates to a process for the preparation of 1-(3-chlorophenyl)-4-methyl-7,8-dimethoxy-5 H-2,3-benzodiazepine of formula (I) ##STR1## in high purity and in a quality suitable for pharmaceutical purposes. According to the invention the reaction of 1 mole of 2-acet |
| 5204343 |
5H-benzodiazepin derivative |
April 20, 1993 |
| The invention relates to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine of formula (I) ##STR1## and pharmaceutically acceptable acid addition salts thereof, furthermore to a process for preparing these compounds.The compounds according to the inven |
| 4840948 |
1-(hydroxystyrl)-5H-2,3-benzodiazepine derivatives, and pharmaceutical compositions containing t |
June 20, 1989 |
| This invention relates to new 1-(hydroxystyryl)-5H-2,3-benzodiazepine derivatives of the general formula (I) and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R stands for a hydrogen or halogen atom, or |
| 4835152 |
1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-b enzodiazepine and acid additio |
May 30, 1989 |
| The invention relates to new 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiaz epi ne of formula (1), optically active isomers and acid addition salts thereof as well as to pharmaceutical compositions containing these compounds. ##STR1## The new compou |
| 4785104 |
3-(hydroxymethyl)-isoquinoline derivatives |
November 15, 1988 |
| This invention relates to new 3-(hydroxymethyl)-isoquinoline derivatives of the general formula (I), their acid addition salts, and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R and R.sup.1 are identic |
| 4614740 |
5H-2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same |
September 30, 1986 |
| The invention relates to new 5H-2,3-benzodiazepine derivatives and a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same.The new 5H-2,3-benzodiazepine derivatives of the invention possess valuable central nervous effect and in particular ex |
| 4423044 |
3,4-Dihydro-5H-2,3-benzodiazepine derivatives and pharmaceutical use thereof |
December 27, 1983 |
| The invention relates to new 3,4-dihydro-5H-2,3-benzodiazepine derivatives of general formula (I) and pharmaceutically acceptable acid addition salts thereof, ##STR1## wherein R represents a phenyl group optionally carrying one or two substituents selected from the group consisti |
| 4322346 |
5H-2,3-Benzodiazepine derivatives |
March 30, 1982 |
| New 5H-2,3-benzodiazepine derivatives of the formula ##STR1## wherein R is phenyl having a trifluoromethyl or halogen substituent,R.sup.1 is methyl,R.sup.2 is hydrogen,R.sup.3 is methoxy and R.sup.4 is methoxy, and the pharmaceutically acceptable acid addition salts thereof, are potent t |
|
|
|
